Bio-Medical Applications Of North Carolina, Inc. is a medicare approved dialysis facility center in Swansboro, North Carolina and it has 10 dialysis stations. It is located in Carteret county at 1165 Cedar Point Boulevard, Swansboro, NC, 28584.
You can reach out to the office of Bio-Medical Applications Of North Carolina, Inc. at (252) 393-2039. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of North Carolina, Inc. has the following ownership type - Profit. It was first certified by medicare in May, 2015. The medicare id for this facility is 342702 and it accepts patients under medicare ESRD program.
Dialysis Center Profile
| Name | Bio-Medical Applications Of North Carolina, Inc. |
|---|
| Location | 1165 Cedar Point Boulevard, Swansboro, North Carolina |
|---|
| No. of Dialysis Stations | 10 |
|---|
| Medicare ID | 342702 |
|---|
| Managed By | Fresenius Medical Care |
|---|
| Ownership Type | Profit |
|---|
| Late Shifts | No |
|---|
NPI Associated with this Dialysis Facility:
Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of North Carolina, Inc.
from NPPES records by matching pattern on the basis of name, address, phone number etc.
Please use this information accordingly.
| NPI Number | 1205237096 |
| Organization Name | Fresenius Medical Care Sea Spray |
| Doing Business As | Bio-medical Applications Of North Carolina, Inc. |
| Address | 1165 Cedar Point Boulevard Cedar Point, North Carolina, 28584 |
| Phone Number | (252) 393-2039 |
Patient Distribution
Anemia Management
| Dialysis patients with Hemoglobin data | 24 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 13 |
Dialysis Adequacy
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
- Hemodialysis
| Adult patients getting regular hemodialysis at the center | 33 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 254 |
| Percentage of adult patients getting regular hemodialysis at the center | 93 |
- Peritoneal Dialysis
| Adult patients getting regular peritoneal dialysis at the center | 23 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 144 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 90 |
Mineral and Bone Disorder
An important goal of dialysis is to maintain normal levels of various minerals
in the body, such as calcium. This shows the percentage of patients
treated at Bio-Medical Applications Of North Carolina, Inc. with elevated calcium levels.
| Patients with hypercalcemia | 61 |
| Hypercalcemia patient months | 467 |
| Patients with Serumphosphor | 65 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 30 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 11 |
Vascular Access
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it
allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access.
Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 67 |
| Patient months included in arterial venous fistula and catheter summaries | 294 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 84 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 7 |
Infection Rate
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to
enter the body and cause infection. This information shows how often patients at Bio-Medical Applications Of North Carolina, Inc. get infections in their blood each year
compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| SIR: Upper Confidence Limit | 2.54 |